Results 21 to 30 of about 62,620 (348)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis

Pathologica, 2021
Summary Autoimmune cholestatic liver diseases are rare hepato-biliary disorders characterized by a progressive, inflammatory destruction of bile ducts.
S. Sarcognato, D. Sacchi, F. Grillo, N. Cazzagon, L. Fabris, M. Cadamuro, I. Cataldo, C. Covelli, A. Mangia, M. Guido   +9 more
semanticscholar   +1 more source

Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports

Journal of Medical Case Reports, 2023
Background Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis is an extremely rare condition that has been reported in only few published cases so far in the literature.
Haythem Yacoub, Sarra Ben Azouz, Hajer Hassine, Habiba Debbabi, Dhouha Cherif, Feriel Ghayeb, Seif Boukriba, Héla Kchir, Nadia Maamouri   +8 more
doaj   +1 more source

Impact on follow‐up strategies in patients with primary sclerosing cholangitis

Liver international (Print), 2022
Evidence for the benefit of scheduled imaging for early detection of hepatobiliary malignancies in primary sclerosing cholangitis (PSC) is limited.
A. Bergquist, T. Weismüller, C. Levy, C. Rupp, D. Joshi, J. Nayagam, A. Montaño-Loza, E. Lytvyak, E. Wunsch, P. Milkiewicz, R. Zenouzi, C. Schramm, N. Cazzagon, A. Floreani, Ingalill Friis Liby, M. Wiestler, H. Wedemeyer, Taotao Zhou, C. Strassburg, E. Rigopoulou, G. Dalekos, Manasa Narasimman, X. Verhelst, H. Degroote, M. Vesterhus, A. Kremer, Bennet Bündgens, F. Rorsman, E. Nilsson, K. Jørgensen, Erik von Seth, Martin Cornillet, N. Nyhlin, H. Martin, S. Kechagias, K. Wiencke, Mårten Werner, B. Terziroli Beretta‐Piccoli, M. Marzioni, H. Isoniemi, J. Arola, A. Wefer, J. Söderling, M. Färkkilä, H. Lenzen   +44 more
semanticscholar   +1 more source

Health disparities in chronic liver disease

Hepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew   +3 more
wiley   +1 more source

A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation

Hepatology, EarlyView., 2022
In this study of the gut mucosal microbiota in primary sclerosing cholangitis (PSC), we found consistent microbiota features associated with PSC and recurrent PSC, PSC with inflammatory bowel disease and a persistent gut dysbiosis after liver transplantation Abstract Background and Aims Several characteristic features of the fecal microbiota have been ...
Mikal Jacob Hole, Kristin Kaasen Jørgensen, Kristian Holm, Peder R. Braadland, Malin Holm Meyer‐Myklestad, Asle Wilhelm Medhus, Dag Henrik Reikvam, Alexandra Götz, Krzysztof Grzyb, Kirsten Muri Boberg, Tom Hemming Karlsen, Martin Kummen, Johannes R. Hov   +12 more
wiley   +1 more source

Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases [PDF]

, 2020
In the past ten years, our understanding of the importance of bile acids has expanded from fat absorption and glucose/lipid/energy homeostasis into potential therapeutic targets for amelioration of chronic cholestatic liver diseases.
Alpini, Gianfranco, Francis, Heather, Kennedy, Lindsey, Kundu, Debjyoti, Meadows, Vik   +4 more
core   +1 more source

Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review

Journal of Clinical and Translational Hepatology, 2022
Primary sclerosing cholangitis is a disease affecting around 0.006–0.016% of the population. Of these, around 75% have concomitant inflammatory bowel disease (IBD) according to the most recent epidemiological studies.
Teresa Da Cunha, Haleh Vaziri, George Y Wu   +2 more
semanticscholar   +1 more source

Primary sclerosing cholangitis

Medicine, 1984
Primary sclerosing cholangitis (PSC) is a chronic, cholestatic liver disease caused by diffuse inflammation and fibrosis that can involve the entire biliary tree. The progressive pathological process obliterates intrahepatic and extrahepatic bile ducts, leading ultimately to biliary cirrhosis, portal hypertension and hepatic failure.
E R, Dickson, N F, LaRusso, R H, Wiesner
openaire   +5 more sources

The natural history of primary sclerosing cholangitis in 781 children. A multicenter, international collaboration [PDF]

, 2017
There are limited data on the natural history of primary sclerosing cholangitis (PSC) in children. We aimed to describe the disease characteristics and long-term outcomes of pediatric PSC.
Abdou, Reham, Alqoaer, Khaled, Amin, Mansi, Amir, Achiya Z, Auth, Marcus, Bazerbachi, Fateh, Broderick, Annemarie, Chan, Albert, Cotter, Jillian, Deneau, Mark R, Doan, Sylvia, El-Matary, Wael, El-Youssef, Mounif, Ferrari, Federica, Furuya, Katryn N, Gottrand, Frederic, Gottrand, Madeleine, Gupta, Nitika, Homan, Matjaz, Iorio, Raffaele, Jensen, M K, Kamath, Binita M, Kolho, Kaija-Leena, Konidari, Anastasia, Koot, Bart, Ledder, Oren, Mack, Cara, Martinez, Mercedes, Miloh, Tamir, Mo Kim, Kyung, Mohan, Parvathi, O'Cathain, Niamh, Papadopoulou, Alexandra, Ricciuto, Amanda, Sathya, Pushpa, Saubermann, Lawrence, Shteyer, Eyal, Smolka, Vratislav, Tanaka, Atushi, Valentino, Pamela L, Varier, Raghu, Venkat, Veena, Vitola, Bernadette, Vos, Miriam B, Woynarowski, Marek, Yap, Jason   +45 more
core   +6 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source